Most private insurers waived cost-sharing for COVID-19 treatment early in the pandemic. Some insurers started phasing out these waivers last November, and even more followed suit after COVID-19 vaccines became widely available in the U.S.
The research team looked at the two largest health plans in each state and Washington, D.C. They found that as of Aug. 12, 72 percent of these plans are no longer waiving cost-sharing for COVID-19 treatment, and another 10 percent of plans have planned to phase out the waivers by the end of October.
During the first seven months of 2021, about one-third of employers said their largest plan waived cost-sharing for COVID-19 treatment.
The typical deductible for an employer health plan is $1,644, and a patient hospitalized for COVID-19 could incur out-of-pocket costs amounting to about $1,300, according to the report.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.